FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912806340> ?p ?o ?g. }

• W2912806340 abstract "Due to the significant heterogeneity of renal cell carcinoma (RCC), immune checkpoints may express differently between primary and metastatic tumor. We aimed to evaluate the differential expression of TIM-3 between the primary and metastatic sites of RCC.Cases of RCC with metastases resected or biopsied at West China Hospital between January 2009 and November 2016 were included. Clinicopathological parameters were retrospectively extracted. SPPS 22.0, GraphPad Prism 6 and R statistical software were applied for data analysis.A total of 163 cases were included. Immunohistochemical results showed that the overall detection rate of TIM-3 was 56.4% (92/163). The detection rate of TIM-3 in the primary (53.0%, 44/83) was numerically higher than that of the metastasis (42.6%,79/174). Although the concordance rate of TIM-3 between the primary and metastasis was as high as 66.3% (55/83) in the paired cohort, a significant statistically difference of TIM-3 expression between the primary and metastasis was observed (χ2 = 4.664, p = 0.002), with a poor consistency (Kappa = 0.331, p = 0.002). Subsequent survival analysis suggested that TIM-3 expression either in the primary or metastatic tumor was associated with longer progression-free survival (PFS) (HR: 0.67, 95% CI 0.45-0.99, P = 0.02) and overall survival (OS) (HR: 0.52, 95% CI 0.33-0.82, P < 0.001). The expressions of TIM-3 in the primary, metastatic tumors and patients treated with targeted agents all played as favorable factors for PFS and OS. Further multivariate analysis showed that, in the whole cohort, TIM-3 expression in metastatic tumor increased the predicted accuracy (PA) of the whole model of PFS from 74.7 to 75.6% (P = 0.02). For OS, the PA of whole model was increased from 78.1 to 81.1% by adding TIM-3 expression in the metastasis (P = 0.005). The same trends were also observed in paired patients and patients treated with targeted agents. In conclusion, the expression difference between the primary and metastatic tumor of TIM-3 was significant. Biopsy or resection of the metastases may provide a more accurate biological information for clinician's decision-making and the patient's prognosis. What's more, the role of TIM-3 in the RCC still remains controversy, further study are needed to verify the conclusion." @default.
• W2912806340 created "2019-02-21" @default.
• W2912806340 creator A5001892235 @default.
• W2912806340 creator A5007113754 @default.
• W2912806340 creator A5010446878 @default.
• W2912806340 creator A5014929343 @default.
• W2912806340 creator A5015805356 @default.
• W2912806340 creator A5025567893 @default.
• W2912806340 creator A5030769859 @default.
• W2912806340 creator A5042481304 @default.
• W2912806340 creator A5052689516 @default.
• W2912806340 creator A5065096073 @default.
• W2912806340 creator A5075732221 @default.
• W2912806340 creator A5082745531 @default.
• W2912806340 creator A5091661753 @default.
• W2912806340 date "2019-01-10" @default.
• W2912806340 modified "2023-10-17" @default.
• W2912806340 title "Differential expression of TIM-3 between primary and metastatic sites in renal cell carcinoma" @default.
• W2912806340 cites W1614133026 @default.
• W2912806340 cites W1860591201 @default.
• W2912806340 cites W1872256430 @default.
• W2912806340 cites W1966034643 @default.
• W2912806340 cites W1969963445 @default.
• W2912806340 cites W1974193263 @default.
• W2912806340 cites W1982488143 @default.
• W2912806340 cites W1996890691 @default.
• W2912806340 cites W1998618704 @default.
• W2912806340 cites W2021725413 @default.
• W2912806340 cites W2066671159 @default.
• W2912806340 cites W2086970364 @default.
• W2912806340 cites W2099088585 @default.
• W2912806340 cites W2101670384 @default.
• W2912806340 cites W2107777135 @default.
• W2912806340 cites W2123914905 @default.
• W2912806340 cites W2134130131 @default.
• W2912806340 cites W2135707184 @default.
• W2912806340 cites W2135744728 @default.
• W2912806340 cites W2145024411 @default.
• W2912806340 cites W2148706732 @default.
• W2912806340 cites W2171095535 @default.
• W2912806340 cites W2171469612 @default.
• W2912806340 cites W2201308017 @default.
• W2912806340 cites W2395145382 @default.
• W2912806340 cites W2553481676 @default.
• W2912806340 cites W2560367415 @default.
• W2912806340 cites W2572174216 @default.
• W2912806340 cites W2578528809 @default.
• W2912806340 cites W2593059553 @default.
• W2912806340 cites W2746829926 @default.
• W2912806340 cites W2766986821 @default.
• W2912806340 cites W329302102 @default.
• W2912806340 doi "https://doi.org/10.1186/s12885-019-5273-5" @default.
• W2912806340 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6329070" @default.
• W2912806340 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30630458" @default.
• W2912806340 hasPublicationYear "2019" @default.
• W2912806340 type Work @default.
• W2912806340 sameAs 2912806340 @default.
• W2912806340 citedByCount "18" @default.
• W2912806340 countsByYear W29128063402019 @default.
• W2912806340 countsByYear W29128063402020 @default.
• W2912806340 countsByYear W29128063402021 @default.
• W2912806340 countsByYear W29128063402022 @default.
• W2912806340 countsByYear W29128063402023 @default.
• W2912806340 crossrefType "journal-article" @default.
• W2912806340 hasAuthorship W2912806340A5001892235 @default.
• W2912806340 hasAuthorship W2912806340A5007113754 @default.
• W2912806340 hasAuthorship W2912806340A5010446878 @default.
• W2912806340 hasAuthorship W2912806340A5014929343 @default.
• W2912806340 hasAuthorship W2912806340A5015805356 @default.
• W2912806340 hasAuthorship W2912806340A5025567893 @default.
• W2912806340 hasAuthorship W2912806340A5030769859 @default.
• W2912806340 hasAuthorship W2912806340A5042481304 @default.
• W2912806340 hasAuthorship W2912806340A5052689516 @default.
• W2912806340 hasAuthorship W2912806340A5065096073 @default.
• W2912806340 hasAuthorship W2912806340A5075732221 @default.
• W2912806340 hasAuthorship W2912806340A5082745531 @default.
• W2912806340 hasAuthorship W2912806340A5091661753 @default.
• W2912806340 hasBestOaLocation W29128063401 @default.
• W2912806340 hasConcept C121608353 @default.
• W2912806340 hasConcept C126322002 @default.
• W2912806340 hasConcept C142724271 @default.
• W2912806340 hasConcept C143998085 @default.
• W2912806340 hasConcept C160798450 @default.
• W2912806340 hasConcept C204232928 @default.
• W2912806340 hasConcept C2777472916 @default.
• W2912806340 hasConcept C2779013556 @default.
• W2912806340 hasConcept C2780140570 @default.
• W2912806340 hasConcept C2780283643 @default.
• W2912806340 hasConcept C71924100 @default.
• W2912806340 hasConceptScore W2912806340C121608353 @default.
• W2912806340 hasConceptScore W2912806340C126322002 @default.
• W2912806340 hasConceptScore W2912806340C142724271 @default.
• W2912806340 hasConceptScore W2912806340C143998085 @default.
• W2912806340 hasConceptScore W2912806340C160798450 @default.
• W2912806340 hasConceptScore W2912806340C204232928 @default.
• W2912806340 hasConceptScore W2912806340C2777472916 @default.
• W2912806340 hasConceptScore W2912806340C2779013556 @default.
• W2912806340 hasConceptScore W2912806340C2780140570 @default.
• W2912806340 hasConceptScore W2912806340C2780283643 @default.
• W2912806340 hasConceptScore W2912806340C71924100 @default.

• next